KNOXVILLE, TN, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that new data from the…
Sei Network – a decentralized layer-1 that is building a network-wide order-book exchange on the Cosmos ecosystem – announces today…
Argenica Therapeutics (AGN) reports no initial safety issues in the sentinel group…...…
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
- Data indicate continued clinical responses with an acceptable safety profile in heavily pre-treated patients with late-stage synovial sarcoma after…
While he remains one of the best players of his generation, that cohort is starting to consider hanging up its…
Leaders in government, business, advocacy, media, and the arts will engage with the AU community to address 21st century challenges…
ANNAPOLIS, Md., Nov. 15, 2022 /PRNewswire/ -- Alphyn Biologics, a clinical-stage dermatology company developing first-in-class multi-target therapeutics, announced today that…
- Multiple Phase 2 readouts for EDP1815 in atopic dermatitis expected in 2023; data from first three cohorts expected in…
Tech Equity Working Group tackles seed founder funding to close the gap in Chicago and to encourage others to directly…
EMERYVILLE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage biotherapeutics company…
The IBM Sustainability Accelerator is a two-year commitment focused on building all necessary skills to allow government and non-profits to…
PHILADELPHIA and VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:…
KNOXVILLE, TN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from the Companys…
Staffordshire University has welcomed a new cohort of British Army degree apprentices committed to progressing their careers by enrolling in…
First-, Second- and Third-Year High School Mathematics and Science Teachers Are Eligible for 2023 Fellowship MOORESTOWN, N.J., Nov. 8, 2022…
New responses in ovarian and urothelial cancers increase ORR to 52% from 44% in heavily pre-treated patients with late-stage ovarian,…
DUBLIN and CHICAGO, Nov. 7, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the…
Clinical interim data reported earlier today from GOBLET trials pancreatic cancer cohort show an objective response rate (ORR) nearly triple…
- New analysis of cohort 7 data using a three-reader pathologist panel showed that 6/19 patients scored as having fibrosis…
SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused…
LONDON, Ontario, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader…
Interim Clinical Data from Phase 1/2 Trial of Pegtarviliase Expected in Fourth Quarter of 2022; Currently Dosing Cohort 3 at…
Oslo, Norway, 3 November 2022 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target…
OpenAI, the San Francisco-based lab behind AI systems like GPT-3 and DALL-E 2, today launched a new program to provide…
– Two confirmed partial responses to SFR388 monotherapy treatment in squamous NSCLC; third patient with NSCLC experienced durable disease stabilization for…
Argenica Therapeutics (AGN) receives approval from the safety review committee (SRC) to…...…
Imugene (IMU) begins dosing the second cohort in its phase one study…...…
NEENAH, Wis., Oct. 27, 2022 /PRNewswire/ -- Georgia-Pacific, in partnership with global venture firm and startup accelerator gener8tor, has kicked…
Alongside Cracker Barrel Old Country Store®, Gibson, Uncle Nearest Premium Whiskey, gener8tor, and Song House, Cohort Zero is a two-day…
LOS ANGELES, Oct. 26, 2022 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2022 Young Investigator…
Futures Slide As Tech Giants Shed $300 Billion; Dollar Tumbles For 2nd Day
…
A study by Prescient Therapeutics (ASX: PTX) into the effects of lead drug PTX-100 on relapsed and refractory T-cell lymphomas…
Big Tech Profits Set To Fall Most In Three Years
…
Phase 2a trial of MORF-057 in patients with ulcerative colitis will extend enrollment to allow patients currently screened to enter…
A new startup wants to help online media outlets make money by making it easier for consumers to access paywalled…
A new company is taking a leaf out of Stripe’s API playbook with a platform that makes it easy for…
Faron Pharmaceuticals Ltd.
(“Faron or Company”)
Faron Pharmaceuticals Presents Results from PD-1 Blockade Refractory Melanoma Cohort of MATINS Trial at 19th International…
Exceptional Students From Around the World Gear Up for New Challenges and Opportunities NEW YORK, Oct. 17, 2022 /PRNewswire/ --…
Company enters what it expects to be the final MAD cohort in the first-in-human Phase 1a designed to establish a…
Dosing in KT-474 Phase 1 HS and AD patient cohort (Part C) complete...…
NEW YORK, Oct. 13, 2022 /PRNewswire/ -- InsurTech NY, the largest InsurTech community in North America, announced today its third…
• No safety concerns noted in ongoing clinical trial• Study timeline remains on track...…
Clinical data from dual combination COM701/nivolumab MSS-CRC cohort expansion study Research data on differentiation of PVRIG from other immune checkpoints…
Enrollment complete for the high-dose third cohort of Phase 1b study of ADS051 in patients with moderate-to-severe ulcerative colitis Company…
Oslo, 5 October 2022: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, announced…
LONDON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the first…
- TransCon TLR7/8 Agonist continued to be well-tolerated and demonstrated early signs of clinical activity as monotherapy or in combination…